Increased gonorrhoea and chlamydia testing did not increase case detection in an HIV clinical cohort 1999-2007
- PMID: 21745834
- PMCID: PMC3174330
- DOI: 10.1136/sextrans-2011-050051
Increased gonorrhoea and chlamydia testing did not increase case detection in an HIV clinical cohort 1999-2007
Abstract
Objectives: Since 2003, US organisations have recommended universal screening, rather than targeted screening, of HIV-infected persons for gonorrhoea and chlamydia. The objective of this study was to determine whether wider testing resulting from these guidelines would produce an increase in gonorrhoea/chlamydia diagnoses.
Methods: 3283 patients receiving HIV care in 1999-2007 in the Johns Hopkins Hospital HIV clinic were studied. The two primary outcomes were the occurrence of any gonorrhoea/chlamydia testing in each year of care and the occurrence of any positive result(s) in years of testing. The proportion of all patients in care who were diagnosed with gonorrhoea/chlamydia was defined as the number of patients with positive results divided by the number of patients in care. Trends were analysed with repeated measures logistic regression.
Results: The proportion of patients tested for gonorrhoea/chlamydia increased steadily from 0.12 in 1999 to 0.33 in 2007 (OR per year for being tested 1.17, 95% CI 1.15 to 1.19). The proportion positive among those tested decreased significantly after 2003 (OR per year 0.67, 95% CI 0.55 to 0.81). The proportion of all patients in care diagnosed with gonorrhoea/chlamydia therefore remained generally stable in 1999-2007 (OR per year 0.97, 95% CI 0.91 to 1.04).
Conclusions: Universal annual screening, as implemented, did not increase the proportion of all patients in care who were diagnosed with gonorrhoea/chlamydia. Similarly low implementation rates have been reported in cross-sectional studies. If future efforts to enhance implementation do not yield increases in diagnoses, then guidelines focusing on targeted screening of high-risk groups rather than universal screening may be warranted.
Conflict of interest statement
Figures
References
-
- Cohen MS, Hoffman IF, Royce RA, et al. Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group. Lancet. 1997;349:1868–73. - PubMed
-
- McClelland RS, Wang CC, Mandaliya K, et al. Treatment of cervicitis is associated with decreased cervical shedding of HIV-1. AIDS. 2001;15:105–10. - PubMed
-
- Johnson LF, Lewis DA. The effect of genital tract infections on HIV-1 shedding in the genital tract: a systematic review and meta-analysis. Sex Transm Dis. 2008;35:946–59. - PubMed
-
- Fisher JD, Fisher WA, Cornman DH, et al. Clinician-delivered intervention during routine clinical care reduces unprotected sexual behavior among HIV-infected patients. J Acquir Immune Defic Syndr. 2006;41:44–52. - PubMed
Publication types
MeSH terms
Grants and funding
- R01 AA016893/AA/NIAAA NIH HHS/United States
- R01 DA011602/DA/NIDA NIH HHS/United States
- K23AI084854/AI/NIAID NIH HHS/United States
- K24 DA000432/DA/NIDA NIH HHS/United States
- KL2RR025006-01/RR/NCRR NIH HHS/United States
- K23 HD056957/HD/NICHD NIH HHS/United States
- KL2 RR025006/RR/NCRR NIH HHS/United States
- K24 DA00432/DA/NIDA NIH HHS/United States
- R01 AG026250/AG/NIA NIH HHS/United States
- U01 AI069918/AI/NIAID NIH HHS/United States
- R01 AA16893/AA/NIAAA NIH HHS/United States
- K23 AI084854/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical